Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Journal of Clinical Pharmacology|September 1, 1996
Pharmacokinetics of tirilazad and U-89678 in ischemic stroke patients receiving a loading regimen and maintenance regimen of 10 mg/kg/day of tirilazadJ C Fleishaker, G R PetersTopics in Health Care Financing|January 1, 1994
Tax exemption and integrated delivery systemsW J Aseltyne, G R PetersThe Journal of Antimicrobial Chemotherapy|April 1, 1989
The effects of cefmetazole and latamoxef on platelet function in healthy human volunteersG R Peters, C M MetzlerInternational Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteersJ C Fleishaker, L K Hulst, G R PetersJournal of Clinical Pharmacology|February 1, 1993
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administrationJ C Fleishaker, G R Peters, K S CathcartJournal of Pharmaceutical Sciences|March 1, 1995
Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A inductionJ C Fleishaker, L K Pearson, G R PetersJournal of Clinical Pharmacology|August 1, 1994
Lack of a pharmacokinetic/pharmacodynamic interaction between nimodipine and tirilazad mesylate in healthy volunteersJ C Fleishaker, L K Hulst, G R PetersBiopharmaceutics & Drug Disposition|April 9, 1998
Induction of tirilazad clearance by phenytoinJ C Fleishaker, L K Pearson, G R PetersEuropean Journal of Clinical Pharmacology|January 1, 1996
Gender does not affect the degree of induction of tirilazad clearance by phenobarbitalJ C Fleishaker, L K Pearson, G R PetersClinical Pharmacology and Therapeutics|October 1, 1994
The effect of phenytoin on the pharmacokinetics of tirilazad mesylate in healthy male volunteersJ C Fleishaker, L K Hulst, G R PetersPageof 5